Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Helicobacter Pylory infection in patients with esophageal squamous cell carcinoma.

Poyrazoglu OB, Dulger AC, Gultepe BS.

Clinics (Sao Paulo). 2017 Mar;72(3):150-153. doi: 10.6061/clinics/2017(03)04.

2.

Discordance of Somatic Mutations Between Asian and Caucasian Patient Populations with Gastric Cancer.

Jia F, Teer JK, Knepper TC, Lee JK, Zhou HH, He YJ, McLeod HL.

Mol Diagn Ther. 2017 Apr;21(2):179-185. doi: 10.1007/s40291-016-0250-z.

PMID:
28039579
3.

Expression of CDX2 in gastric cardia adenocarcinoma and its correlation with H. pylori and cell proliferation.

Zhang Y, Wang H, Bi C, Xiao Y, Liu Z.

Oncotarget. 2016 Aug 23;7(34):54973-54982. doi: 10.18632/oncotarget.10362.

4.

Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up.

Vohlonen I, Pukkala E, Malila N, Härkönen M, Hakama M, Koistinen V, Sipponen P.

Scand J Gastroenterol. 2016 Oct;51(10):1159-64. doi: 10.1080/00365521.2016.1183225. Epub 2016 Jun 24.

5.

Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study.

Chen XZ, Schöttker B, Castro FA, Chen H, Zhang Y, Holleczek B, Brenner H.

Oncotarget. 2016 Mar 29;7(13):17182-93. doi: 10.18632/oncotarget.7946.

6.

Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.

Wang Z, Dai J, Hu N, Miao X, Abnet CC, Yang M, Freedman ND, Chen J, Burdette L, Zhu X, Chung CC, Ren C, Dawsey SM, Wang M, Ding T, Du J, Gao YT, Zhong R, Giffen C, Pan W, Koh WP, Dai N, Liao LM, Yan C, Qiao YL, Jiang Y, Shu XO, Chen J, Wang C, Ma H, Su H, Zhang Z, Wang L, Wu C, Xiang YB, Hu Z, Yuan JM, Xie L, Zheng W, Lin D, Chanock SJ, Shi Y, Goldstein AM, Jin G, Taylor PR, Shen H.

Gut. 2017 Apr;66(4):581-587. doi: 10.1136/gutjnl-2015-310612. Epub 2015 Dec 23.

7.

Helicobacter pylori in gastric carcinogenesis.

Ahn HJ, Lee DS.

World J Gastrointest Oncol. 2015 Dec 15;7(12):455-65. doi: 10.4251/wjgo.v7.i12.455. Review.

8.

Unique Clinicopathology of Proximal Gastric Carcinoma: A Critical Review.

Huang Q.

Gastrointest Tumors. 2014 Aug;1(3):115-22. doi: 10.1159/000365305. Epub 2014 Jul 18. Review.

9.

Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.

Shakeri R, Malekzadeh R, Nasrollahzadeh D, Pawlita M, Murphy G, Islami F, Sotoudeh M, Michel A, Etemadi A, Waterboer T, Poustchi H, Brennan P, Boffetta P, Dawsey SM, Kamangar F, Abnet CC.

Cancer Res. 2015 Nov 15;75(22):4876-83. doi: 10.1158/0008-5472.CAN-15-0556. Epub 2015 Sep 17. Erratum in: Cancer Res. 2016 Mar 1;76(5):1297. Pawilta, Michael [corrected to Pawlita, Michael].

10.

Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids.

Mukaisho K, Nakayama T, Hagiwara T, Hattori T, Sugihara H.

Front Microbiol. 2015 May 11;6:412. doi: 10.3389/fmicb.2015.00412. eCollection 2015.

11.

Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.

Murphy G, Freedman ND, Michel A, Fan JH, Taylor PR, Pawlita M, Qiao YL, Zhang H, Yu K, Abnet CC, Dawsey SM.

Int J Cancer. 2015 Oct 15;137(8):1938-46. doi: 10.1002/ijc.29543. Epub 2015 May 5.

12.

Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia.

Nasrollahzadeh D, Malekzadeh R, Ploner A, Shakeri R, Sotoudeh M, Fahimi S, Nasseri-Moghaddam S, Kamangar F, Abnet CC, Winckler B, Islami F, Boffetta P, Brennan P, Dawsey SM, Ye W.

Sci Rep. 2015 Mar 6;5:8820. doi: 10.1038/srep08820.

13.

The unique phenotypes of adenocarcinoma of the esophagogastric junction in China.

Feng M, Guan W.

Chin J Cancer Res. 2014 Jun;26(3):224-5. doi: 10.3978/j.issn.1000-9604.2014.06.13. No abstract available.

14.

Gastric cardia adenocarcinoma pathway analysis.

Zali H, Rezaei-Tavirani M, Vafaee R, Rezaei-Tavirani M.

Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S11-8.

15.

Evaluation of routine biopsies in endoscopic screening for esophagogastric junction cancer.

Niu X, Wei WQ, Hao CQ, Song GH, Li J, Hua ZL, Li YW, Chang J, Wang XZ, Zhao DL, Wang GQ, Hsieh E, Qiao YL.

World J Gastroenterol. 2014 May 7;20(17):5074-81. doi: 10.3748/wjg.v20.i17.5074.

16.

Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach.

Yu G, Gail MH, Shi J, Klepac-Ceraj V, Paster BJ, Dye BA, Wang GQ, Wei WQ, Fan JH, Qiao YL, Dawsey SM, Freedman ND, Abnet CC.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):735-41. doi: 10.1158/1055-9965.EPI-13-0855. Epub 2014 Apr 3.

17.

Identification of biomarkers for esophageal squamous cell carcinoma using feature selection and decision tree methods.

Tung CW, Wu MT, Chen YK, Wu CC, Chen WC, Li HP, Chou SH, Wu DC, Wu IC.

ScientificWorldJournal. 2013 Dec 12;2013:782031. doi: 10.1155/2013/782031. eCollection 2013.

18.

Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis.

Xie FJ, Zhang YP, Zheng QQ, Jin HC, Wang FL, Chen M, Shao L, Zou DH, Yu XM, Mao WM.

World J Gastroenterol. 2013 Sep 28;19(36):6098-107. doi: 10.3748/wjg.v19.i36.6098. Review.

19.

Prediagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in a Chinese population.

Lam TK, Freedman ND, Fan JH, Qiao YL, Dawsey SM, Taylor PR, Abnet CC.

Am J Clin Nutr. 2013 Nov;98(5):1289-97. doi: 10.3945/ajcn.113.061267. Epub 2013 Sep 11.

20.

Genetic variants in fas signaling pathway genes and risk of gastric cancer.

Hyland PL, Lin SW, Hu N, Zhang H, Wang L, Su H, Wang C, Ding T, Tang ZZ, Fan JH, Qiao YL, Xiong X, Wheeler W, Giffen C, Yu K, Yuenger J, Burdett L, Wang Z, Chanock SJ, Tucker MA, Dawsey SM, Freedman ND, Goldstein AM, Abnet CC, Taylor PR.

Int J Cancer. 2014 Feb 15;134(4):822-31. doi: 10.1002/ijc.28415. Epub 2013 Sep 11.

Supplemental Content

Support Center